Study of a New Technique for Imaging Pancreatic Cancer
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how well the experimental imaging agent
89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done
with this imaging agent produce better images of cancer.